Table 1:

Patient characteristics by postoperative albumin levels

Albumin ≥3 g/dl (N = 173)Albumin <3 g/dl (N = 56)P-value
Preoperative recipient characteristics
 Male sex129 (74.6)38 (67.9)0.387
 Age (years)55.1 ± 10.855.3 ± 110.904
 BMI (kg/m2)25.8 ± 4.525.4 ± 4.70.614
 Smoker45 (26.2)12 (21.4)0.594
 Diabetes32 (18.7)18 (32.1)0.042
 Arterial hypertension98 (57)32 (57.1)>0.999
 Pulmonary hypertension14 (8.1)7 (12.5)0.424
 Prior cardiothoracic surgery101 (58.4)44 (78.6)0.007
 LVAD78 (45.1)37 (66.1)0.009
 ICM73 (42.4)25 (44.6)0.877
 DCM81 (47.1)28 (50)0.759
 ARVC7 (4.1)1 (1.8)0.683
 RCM0 (0)1 (1.8)0.246
 HCM3 (1.7)1 (1.8)>0.999
 Myocarditis2 (1.2)0 (0)>0.999
 Preoperative dialysis10 (5.8)2 (3.7)0.736
 IMPACT score8.1 ± 4.79.4 ± 4.10.096
 Albumin (g/dl)3.9 ± 0.73.7 ± 0.70.185
 MELD score14.3 ± 7.613.7 ± 6.50.652
Donor characteristics
 Male sex98 (56.6)28 (50)0.441
 Age (years)43.1 ± 12.244.3 ± 12.40.526
 BMI (kg/m²)26.1 ± 4.926.0 ± 3.70.945
 Cardiopulmonary resuscitation53 (30.6)15 (26.8)0.618
Intraoperative characteristics (min)
 Duration of surgery401 ± 95490 ± 148<0.001
 Duration of CPB240 ± 57294 ± 94<0.001
 Total ischaemia time212 ± 48220 ± 510.330
 PRBC (l)2.9 ± 2.44.9 ± 3.2<0.001
 Platelets (l)1.0 ± 0.81.5 ± 1.10.001
 FFP (l)1.5 ± 1.61.9 ± 2.30.218
Postoperative laboratory values
 Creatinine (mg/dl)1.5 ± 0.81.3 ± 0.50.230
 Bilirubin (mg/dl)2.6 ± 1.92.5 ± 1.30.576
 INR1.2 ± 1.91.3 ± 2.20.280
 Albumin (g/dl)3.5 ± 0.42.4 ± 0.4<0.001
Postoperative characteristics
 ECMO33 (19.2)28 (50)<0.001
 Renal replacement therapy90 (57.7)35 (62.5)0.635
 MELD score14.6 ± 5.314.3 ± 5.10.711
 Albumin substitution within first 24 h47 (28.7)29 (54.7)0.001
 Days in ICU24 ± 2525 ± 260.677
 Duration of mechanical ventilation (hours)110 ± 167223 ± 2160.001
 30-day mortality6 (3.5)12 (21.4)<0.001
 1-year mortality18 (10.4)22 (39.3)<0.001
Albumin ≥3 g/dl (N = 173)Albumin <3 g/dl (N = 56)P-value
Preoperative recipient characteristics
 Male sex129 (74.6)38 (67.9)0.387
 Age (years)55.1 ± 10.855.3 ± 110.904
 BMI (kg/m2)25.8 ± 4.525.4 ± 4.70.614
 Smoker45 (26.2)12 (21.4)0.594
 Diabetes32 (18.7)18 (32.1)0.042
 Arterial hypertension98 (57)32 (57.1)>0.999
 Pulmonary hypertension14 (8.1)7 (12.5)0.424
 Prior cardiothoracic surgery101 (58.4)44 (78.6)0.007
 LVAD78 (45.1)37 (66.1)0.009
 ICM73 (42.4)25 (44.6)0.877
 DCM81 (47.1)28 (50)0.759
 ARVC7 (4.1)1 (1.8)0.683
 RCM0 (0)1 (1.8)0.246
 HCM3 (1.7)1 (1.8)>0.999
 Myocarditis2 (1.2)0 (0)>0.999
 Preoperative dialysis10 (5.8)2 (3.7)0.736
 IMPACT score8.1 ± 4.79.4 ± 4.10.096
 Albumin (g/dl)3.9 ± 0.73.7 ± 0.70.185
 MELD score14.3 ± 7.613.7 ± 6.50.652
Donor characteristics
 Male sex98 (56.6)28 (50)0.441
 Age (years)43.1 ± 12.244.3 ± 12.40.526
 BMI (kg/m²)26.1 ± 4.926.0 ± 3.70.945
 Cardiopulmonary resuscitation53 (30.6)15 (26.8)0.618
Intraoperative characteristics (min)
 Duration of surgery401 ± 95490 ± 148<0.001
 Duration of CPB240 ± 57294 ± 94<0.001
 Total ischaemia time212 ± 48220 ± 510.330
 PRBC (l)2.9 ± 2.44.9 ± 3.2<0.001
 Platelets (l)1.0 ± 0.81.5 ± 1.10.001
 FFP (l)1.5 ± 1.61.9 ± 2.30.218
Postoperative laboratory values
 Creatinine (mg/dl)1.5 ± 0.81.3 ± 0.50.230
 Bilirubin (mg/dl)2.6 ± 1.92.5 ± 1.30.576
 INR1.2 ± 1.91.3 ± 2.20.280
 Albumin (g/dl)3.5 ± 0.42.4 ± 0.4<0.001
Postoperative characteristics
 ECMO33 (19.2)28 (50)<0.001
 Renal replacement therapy90 (57.7)35 (62.5)0.635
 MELD score14.6 ± 5.314.3 ± 5.10.711
 Albumin substitution within first 24 h47 (28.7)29 (54.7)0.001
 Days in ICU24 ± 2525 ± 260.677
 Duration of mechanical ventilation (hours)110 ± 167223 ± 2160.001
 30-day mortality6 (3.5)12 (21.4)<0.001
 1-year mortality18 (10.4)22 (39.3)<0.001

ARVC, arrhythmogenic right ventricular cardiomyopathy; BMI, body mass index; CPB, cardiopulmonary bypass; DCM, dilative cardiomyopathy; ECMO; extracorporeal membrane oxygenation; FFP, fresh frozen plasma; HCM, hypertrophic cardiomyopathy; ICM, ischaemic cardiomyopathy; IMPACT, risk index for mortality prediction after cardiac transplantation; ICU, intensive care unit; INR, international normalized ratio; LVAD, left ventricular assist device; MELD, model for end-stage liver disease; PRBC, packed red blood cells; RCM, restrictive cardiomyopathy [11].

Significant results are marked in bold.

Table 1:

Patient characteristics by postoperative albumin levels

Albumin ≥3 g/dl (N = 173)Albumin <3 g/dl (N = 56)P-value
Preoperative recipient characteristics
 Male sex129 (74.6)38 (67.9)0.387
 Age (years)55.1 ± 10.855.3 ± 110.904
 BMI (kg/m2)25.8 ± 4.525.4 ± 4.70.614
 Smoker45 (26.2)12 (21.4)0.594
 Diabetes32 (18.7)18 (32.1)0.042
 Arterial hypertension98 (57)32 (57.1)>0.999
 Pulmonary hypertension14 (8.1)7 (12.5)0.424
 Prior cardiothoracic surgery101 (58.4)44 (78.6)0.007
 LVAD78 (45.1)37 (66.1)0.009
 ICM73 (42.4)25 (44.6)0.877
 DCM81 (47.1)28 (50)0.759
 ARVC7 (4.1)1 (1.8)0.683
 RCM0 (0)1 (1.8)0.246
 HCM3 (1.7)1 (1.8)>0.999
 Myocarditis2 (1.2)0 (0)>0.999
 Preoperative dialysis10 (5.8)2 (3.7)0.736
 IMPACT score8.1 ± 4.79.4 ± 4.10.096
 Albumin (g/dl)3.9 ± 0.73.7 ± 0.70.185
 MELD score14.3 ± 7.613.7 ± 6.50.652
Donor characteristics
 Male sex98 (56.6)28 (50)0.441
 Age (years)43.1 ± 12.244.3 ± 12.40.526
 BMI (kg/m²)26.1 ± 4.926.0 ± 3.70.945
 Cardiopulmonary resuscitation53 (30.6)15 (26.8)0.618
Intraoperative characteristics (min)
 Duration of surgery401 ± 95490 ± 148<0.001
 Duration of CPB240 ± 57294 ± 94<0.001
 Total ischaemia time212 ± 48220 ± 510.330
 PRBC (l)2.9 ± 2.44.9 ± 3.2<0.001
 Platelets (l)1.0 ± 0.81.5 ± 1.10.001
 FFP (l)1.5 ± 1.61.9 ± 2.30.218
Postoperative laboratory values
 Creatinine (mg/dl)1.5 ± 0.81.3 ± 0.50.230
 Bilirubin (mg/dl)2.6 ± 1.92.5 ± 1.30.576
 INR1.2 ± 1.91.3 ± 2.20.280
 Albumin (g/dl)3.5 ± 0.42.4 ± 0.4<0.001
Postoperative characteristics
 ECMO33 (19.2)28 (50)<0.001
 Renal replacement therapy90 (57.7)35 (62.5)0.635
 MELD score14.6 ± 5.314.3 ± 5.10.711
 Albumin substitution within first 24 h47 (28.7)29 (54.7)0.001
 Days in ICU24 ± 2525 ± 260.677
 Duration of mechanical ventilation (hours)110 ± 167223 ± 2160.001
 30-day mortality6 (3.5)12 (21.4)<0.001
 1-year mortality18 (10.4)22 (39.3)<0.001
Albumin ≥3 g/dl (N = 173)Albumin <3 g/dl (N = 56)P-value
Preoperative recipient characteristics
 Male sex129 (74.6)38 (67.9)0.387
 Age (years)55.1 ± 10.855.3 ± 110.904
 BMI (kg/m2)25.8 ± 4.525.4 ± 4.70.614
 Smoker45 (26.2)12 (21.4)0.594
 Diabetes32 (18.7)18 (32.1)0.042
 Arterial hypertension98 (57)32 (57.1)>0.999
 Pulmonary hypertension14 (8.1)7 (12.5)0.424
 Prior cardiothoracic surgery101 (58.4)44 (78.6)0.007
 LVAD78 (45.1)37 (66.1)0.009
 ICM73 (42.4)25 (44.6)0.877
 DCM81 (47.1)28 (50)0.759
 ARVC7 (4.1)1 (1.8)0.683
 RCM0 (0)1 (1.8)0.246
 HCM3 (1.7)1 (1.8)>0.999
 Myocarditis2 (1.2)0 (0)>0.999
 Preoperative dialysis10 (5.8)2 (3.7)0.736
 IMPACT score8.1 ± 4.79.4 ± 4.10.096
 Albumin (g/dl)3.9 ± 0.73.7 ± 0.70.185
 MELD score14.3 ± 7.613.7 ± 6.50.652
Donor characteristics
 Male sex98 (56.6)28 (50)0.441
 Age (years)43.1 ± 12.244.3 ± 12.40.526
 BMI (kg/m²)26.1 ± 4.926.0 ± 3.70.945
 Cardiopulmonary resuscitation53 (30.6)15 (26.8)0.618
Intraoperative characteristics (min)
 Duration of surgery401 ± 95490 ± 148<0.001
 Duration of CPB240 ± 57294 ± 94<0.001
 Total ischaemia time212 ± 48220 ± 510.330
 PRBC (l)2.9 ± 2.44.9 ± 3.2<0.001
 Platelets (l)1.0 ± 0.81.5 ± 1.10.001
 FFP (l)1.5 ± 1.61.9 ± 2.30.218
Postoperative laboratory values
 Creatinine (mg/dl)1.5 ± 0.81.3 ± 0.50.230
 Bilirubin (mg/dl)2.6 ± 1.92.5 ± 1.30.576
 INR1.2 ± 1.91.3 ± 2.20.280
 Albumin (g/dl)3.5 ± 0.42.4 ± 0.4<0.001
Postoperative characteristics
 ECMO33 (19.2)28 (50)<0.001
 Renal replacement therapy90 (57.7)35 (62.5)0.635
 MELD score14.6 ± 5.314.3 ± 5.10.711
 Albumin substitution within first 24 h47 (28.7)29 (54.7)0.001
 Days in ICU24 ± 2525 ± 260.677
 Duration of mechanical ventilation (hours)110 ± 167223 ± 2160.001
 30-day mortality6 (3.5)12 (21.4)<0.001
 1-year mortality18 (10.4)22 (39.3)<0.001

ARVC, arrhythmogenic right ventricular cardiomyopathy; BMI, body mass index; CPB, cardiopulmonary bypass; DCM, dilative cardiomyopathy; ECMO; extracorporeal membrane oxygenation; FFP, fresh frozen plasma; HCM, hypertrophic cardiomyopathy; ICM, ischaemic cardiomyopathy; IMPACT, risk index for mortality prediction after cardiac transplantation; ICU, intensive care unit; INR, international normalized ratio; LVAD, left ventricular assist device; MELD, model for end-stage liver disease; PRBC, packed red blood cells; RCM, restrictive cardiomyopathy [11].

Significant results are marked in bold.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close